Registration number: 11177980

Beaumont Square Holdings Limited

(Registration number: 11177980)
Balance Sheet as at 31 March 2025

	2025 £	2024 £
Fixed assets	200	200
Current assets	1,142,400	1,142,400
Creditors: Amounts falling due within one year	(490,215)	(490,215)
Net current assets	652,185	652,185
	652,385	652,385
Capital and reserves	652,385	652,385

Beaumont Square Holdings Limited

(Registration number: 11177980)
Balance Sheet as at 31 March 2025

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Suite 7
Arkleigh Mansions
Brent Street
London
NW4 1BJ

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

	2025  No.	2024  No.
Average number of employees	2	2

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.
 

Approved and authorised by the Board on 16 December 2025 and signed on its behalf by:
 

......................................... R Bloom Director

......................................... H Newman Director